# Clinical Value of FEC-PET Combined With Endorectal MRI for Pre-therapeutic Staging of Prostate Cancer

> **NCT00520546** · PHASE3 · COMPLETED · sponsor: **Dr. Markus Hartenbach** · enrollment: 44 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **OTHER:** 18F-Ethylcholine Positron Emission Tomography (FEC-PET)
- **OTHER:** Endorectal Magnetic Resonance Imaging (1.5Tesla) (eMRI)

## Key facts

- **NCT ID:** NCT00520546
- **Lead sponsor:** Dr. Markus Hartenbach
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2011-02
- **Final completion:** 2011-06
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2012-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00520546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00520546, "Clinical Value of FEC-PET Combined With Endorectal MRI for Pre-therapeutic Staging of Prostate Cancer". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00520546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*